Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-1Ra for aneurysmal subarachnoid haemorrhage
ISRCTN12961797Phase 3Completed
- Sponsor
- The University of Manchester
- Start
- May 2018
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Anakinra with Placebo (2 arms). Primary endpoint: Modified Rankin Scale at 6 months. Started May 2018; status: completed.
02
Drugs
anakinra
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on ISRCTN12961797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12961797.